Skip to main content
. 2021 Sep 14;36:100875. doi: 10.1016/j.ijcha.2021.100875

Table 1.

Demographics and clinical characteristics at baseline.

Variables lopinavir/ritonavir (n = 20) lopinavir/ritonavir + atorvastatin (n = 20) P-value
Gender, N (%) 0.752*
 Male 11(55) 10 (50)
 Female 9 (45) 10 (50)
Age (year), Mean (SD) 45.95 (6.98) 46.10 (6.87) 0.946**
BMI (Kg), Mean (SD) 29 (42) 30 (01) 0.916**
Current smoking, N (%) 14 (70) 15 (75) 0.723*
Underlying conditions, N (%) 0.969*
 Diabetes 3 (15) 2 (10)
 Hypertension 4 (20) 2 (10)
 Lung diseases 2 (10) 1 (5)
Clinical features, N (%)
 Fever 20 (100) 20 (100) 1.000*
 Dyspnea 16 (80) 13 (65) 0.240*
 Myalgia 16 (80) 16 (80) 1.000*
 Anosmia 15 (75) 16 (80) 0.705*
 Diarrhea 7 (35) 6 (30) 0.736*
Cholesterol (mg/dL), Mean (SD) 192.10 (20.21) 201.61 (42.52) 0.372**
Lymphocyte count (109/L), Mean (SD) 745.70 (86.12) 768.85 (67.35) 0.349**
White Blood Cell count (109/L), Mean (SD) 7732.51 (644.21) 7514.11 (377.55) 0.199**
Respiratory rate, Mean(SD) 84.42 (7.13) 87.71 (9.21) 0.214**
C-Reactive protein (CRP) (mg/L), Mean (SD) 43.50 (22.12) 57.70 (19.94) 0.040**

SD: Standard deviation; N: Number; CRP: C-Reactive protein.

*

Chi-Square.

**

Independent T-Test.